Growing community of inventors

Paris, France

Bertrand Bellier

Average Co-Inventor Count = 2.63

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 35

Bertrand BellierDavid Klatzmann (5 patents)Bertrand BellierJean-Loup Salzmann (2 patents)Bertrand BellierFrancois-Loic Cosset (1 patent)Bertrand BellierCharlotte Frisen (1 patent)Bertrand BellierFrançois-Loïc Cosset (1 patent)Bertrand BellierCharlotte Fribert (1 patent)Bertrand BellierTheodora Hatziiannou (0 patent)Bertrand BellierFrançois-Loic Cosset (0 patent)Bertrand BellierBertrand Bellier (5 patents)David KlatzmannDavid Klatzmann (34 patents)Jean-Loup SalzmannJean-Loup Salzmann (10 patents)Francois-Loic CossetFrancois-Loic Cosset (16 patents)Charlotte FrisenCharlotte Frisen (1 patent)François-Loïc CossetFrançois-Loïc Cosset (1 patent)Charlotte FribertCharlotte Fribert (1 patent)Theodora HatziiannouTheodora Hatziiannou (0 patent)François-Loic CossetFrançois-Loic Cosset (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Assistance Publique-hopitaux De Paris (3 from 318 patents)

2. Sorbonne Université (3 from 237 patents)

3. L'universite Pierre Et Marie Curie (2 from 2 patents)

4. Centre National De La Recherche Scientifique (1 from 5,081 patents)

5. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)

6. Inserm (institut National De La Sante Et De La Recherche Medicale) (1 from 38 patents)

7. L'université Pierre Et Marie Curie - (paris 6) (0 patent)


5 patents:

1. 12428625 - Virus-like particles which can be used in the treatment of allergies

2. 11306294 - Virus-like particles which can be used in the treatment of autoimmune diseases

3. 10376564 - Interleukin-2 for treating food allergy

4. 9765304 - Synthetic viruses and uses thereof

5. 8673612 - Synthetic viruses and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…